Trial of Gemcitabine, Cisplatin, and Ifosfamide in Patients With Relapsed Non-Seminomatous Germ-Cell Tumors
Status:
Unknown status
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
This is a prospective multicenter phase II trial of gemcitabine, cisplatin, and ifosfamide
(GIP) in patients with relapsed non-seminomatous germ-cell tumors (NSGCT) and a predicted
favorable prognosis.